Current Portfolio
Nkarta
US biotech company developing engineered natural killer (NK) cell therapies.
Key Facts
- Sector
Life Sciences
- Country
United States
- Fund
LSP 6
- Entry
2019
Website
Do You Want to Know More?
We are eager to explore how we can achieve great things together.